Our Mission
Improving Care
The Maternal Alloimmunization Foundation is dedicated to improving care for families affected by maternal alloimmunization and HDFN, and we know that progress starts with strong clinical partnerships.
The Azalea Trial
The Azalea Trial is a clinical research study of an investigational medication in pregnancies at risk for severe HDFN.
Pregnancy Guidelines
Pregnancy with maternal alloimmunization, also called isoimmunization or sensitization, can be confusing and overwhelming at first.
Birth & Infancy Guidelines
This comprehensive guide provides essential information for parents navigating care after delivery when their baby has been diagnosed with Hemolytic Disease of the Fetus and Newborn (HDFN).
Join Our Medical Advisory Board
Are you passionate about improving care for families affected by maternal alloimmunization and HDFN?
We’re building a collaborative, multidisciplinary Medical Advisory Board to help guide the Maternal Alloimmunization Foundation’s work across education, advocacy, outreach, and research.
Join Our Expert Network
Support Better Outcomes for Families
We’re seeking a diverse group of experts, including neonatologists, MFMs, pediatric hematologists, OB/GYNs, pediatricians, pediatric nurses, and researchers, who share a commitment to:
- Raising awareness of HDFN in both prenatal and neonatal care
- Reducing variation in postnatal monitoring, treatment, and follow-up
- Supporting research and contributing to clinical guidance
- Providing expert input on our educational materials and initiatives
Help Us Build a Postnatal Standard of Care
One of our key priorities is to develop and promote a consistent, evidence-informed postnatal standard of care for babies affected by HDFN. It’s a critical gap in today’s clinical landscape.
Whether you’ve managed hundreds of cases or are early in your career and passionate about improving outcomes, we welcome your voice in this work. Interested in joining?
Clinical Support
Medical Review
We are deeply grateful to the medical professionals who have reviewed our materials and supported our mission to improve care for families facing maternal alloimmunization and HDFN. Their insights help ensure our educational content is accurate, relevant, and rooted in clinical best practices.
Contributors include:
- Dr. Ramen H. Chmait, MD: Professor, University of Southern California, Director, Los Angeles Fetal Surgery
- Timothy M. Bahr, MS, MD: University of Utah & Intermountain Health
- Dr. Paul T. Wilkes, MD, FACOG: Perinatologist, Desert Perinatal Associates, Henderson and Las Vegas, Nevada
- Note: While we do not currently have a formal medical advisory board, we rely on the expertise of these and other dedicated clinicians who help guide our work.
Get Involved with MAF
Whether you’re a parent, provider, advocate, or ally, there’s a role for you in our work. Host a fundraiser, share your story, join an event, or help us raise awareness. Every action makes a difference for families facing maternal alloimmunization and HDFN.